Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Viridian Therapeutics, Inc. (VRDN)

10.7   -0.87 (-7.52%) 07-02 18:41
Open: 11.6 Pre. Close: 11.57
High: 11.61 Low: 10.59
Volume: 168,141 Market Cap: 299(M)
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.62 - 11.69 11.69 - 11.75
Low: 10.45 - 10.51 10.51 - 10.58
Close: 10.6 - 10.71 10.71 - 10.81

Technical analysis

as of: 2022-07-01 4:26:07 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 13.58     One year: 14.87
Support: Support1: 9.84    Support2: 8.18
Resistance: Resistance1: 11.62    Resistance2: 12.73
Pivot: 10.85
Moving Average: MA(5): 10.86     MA(20): 11.06
MA(100): 15.39     MA(250): 16.41
MACD: MACD(12,26): -0.5     Signal(9): -0.6
Stochastic oscillator: %K(14,3): 53.6     %D(3): 44.3
RSI: RSI(14): 43.4
52-week: High: 22  Low: 9.47
Average Vol(K): 3-Month: 345 (K)  10-Days: 693 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VRDN ] has closed above bottom band by 39.2%. Bollinger Bands are 66.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 01 Jul 2022
Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates - GuruFocus.com

Mon, 27 Jun 2022
B. Riley Comments on Viridian Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:VRDN) - Defense World

Thu, 23 Jun 2022
Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer - GlobeNewswire

Tue, 21 Jun 2022
Viridian Therapeutics to Participate in June Investor Conferences - GuruFocus.com

Thu, 16 Jun 2022
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Viridian Therapeutics, Inc. with Losses to Contact the Firm - Business Wire

Mon, 13 Jun 2022
Financial Comparison: Viridian Therapeutics (NASDAQ:VRDN) versus Exact Sciences (NASDAQ:EXAS) - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 22 (M)
% Held by Insiders 1.872e+007 (%)
% Held by Institutions 3.3 (%)
Shares Short 501 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.961e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -2
Return on Assets (ttm) 690.7
Return on Equity (ttm) -29.8
Qtrly Rev. Growth 2.96e+006
Gross Profit (p.s.) 279.52
Sales Per Share -48.69
EBITDA (p.s.) -5.08679e+007
Qtrly Earnings Growth -19.3
Operating Cash Flow 0 (M)
Levered Free Cash Flow -55 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.22
Price to Cash Flow 5.08

Stock Dividends

Dividend 0
Forward Dividend 823450
Dividend Yield 0%
Dividend Pay Date 2020-11-12
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.